Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.70 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA4 | P22748 | 2/20 | 0.52 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | MYC | P01106 | 2/20 | 0.50 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalic Acid SCHEMBL28107851 | 1.00 | ALDH1A1 (0.70) | ALDH1A1ALOX15AKR1C3TDP1CA12 | |
| Phthalic Acid SCHEMBL9164708 | 0.95 | ALDH1A1 (0.64) | ALDH1A1ALOX15AKR1C3TDP1CA12 | |
| Phthalic Acid SCHEMBL27458631 | 0.90 | ALDH1A1 (0.78) | ALDH1A1ALOX15AKR1C3TDP1CA12 | |
| Phthalic Acid SCHEMBL3030281 | 0.88 | ALDH1A1 (0.67) | ALDH1A1ALOX15AKR1C3TDP1CA12 | |
| Phthalic Acid SCHEMBL9132518 | 0.87 | ALDH1A1 (0.74) | ALDH1A1ALOX15AKR1C3TDP1CA12 | |
| Phthalic Acid SCHEMBL1482851 | 0.87 | ALDH1A1 (0.74) | ALDH1A1ALOX15AKR1C3TDP1CA12 | |
| Phthalic Acid SCHEMBL10779822 | 0.87 | ALDH1A1 (0.74) | ALDH1A1ALOX15AKR1C3TDP1CA12 | |
| Toluic Acid SCHEMBL27433951 | 0.87 | ALDH1A1 (0.53) | ALDH1A1ALOX15AKR1C3TDP1KDM4E | |
| SCHEMBL4249140 | 0.86 | ALDH1A1 (0.64) | ALDH1A1ALOX15AKR1C3TDP1CA12 | |
| Phthalic Acid SCHEMBL30933129 | 0.85 | ALDH1A1 (0.70) | ALDH1A1ALOX15AKR1C3TDP1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2155 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024119044-A2 | ADRULIPASE COMPOSITIONS | First Wave BioPharma, Inc. (US) | 2024-06-06 | — | — | WO | claimed |
| CN-118019524-A | Dydrogesterone sustained release pharmaceutical composition | 曼肯制药有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117777555-A | Environment-friendly fresh-keeping film with adjustable air permeability and preparation method and application thereof | 上海海洋大学 | 2024-03-29 | — | — | CN | claimed |
| CN-116437947-A | Non-pig formulations and methods thereof | 第一浪潮生物制药有限公司 | 2023-07-14 | — | — | CN | claimed |
| US-20230201164-A1 | PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND | HK INNO.N CORPORATION (KR) | 2023-06-29 | — | — | US | claimed |
| WO-2023114390-A2 | LIPASE FORMULATIONS AND METHODS THEREOF | First Wave BioPharma, Inc. (US) | 2023-06-22 | — | — | WO | claimed |
| WO-2023095183-A1 | A PHARMACEUTICAL COMPOSITION AND A SOLID DOSAGE FORM THEREOF | JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (JO) | 2023-06-01 | — | — | WO | claimed |
| US-20230135608-A1 | PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE AS AN ACTIVE INGREDIENT PROVIDES A SPECIFIC PHARMACOKINETIC PARAMETER | CURACLE CO., LTD. (KR) | 2023-05-04 | — | — | US | claimed |
| EP-4167970-A1 | NON-PORCINE FORMULATIONS AND METHODS THEREOF | First Wave Biopharma, Inc. (US) | 2023-04-26 | — | — | EP | claimed |
| WO-2023047274-A1 | EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS OF DYDROGESTERONE | MANKIND PHARMA LTD. (IN) | 2023-03-30 | — | — | WO | claimed |
| EP-0653935-A1 | PELLETISED PHARMACEUTICAL COMPOSITION | F.H. FAULDING & CO. LIMITED (AU) | 1995-05-24 | — | — | EP | claimed |
| WO-1994003160-A1 | PELLETISED PHARMACEUTICAL COMPOSITION | F.H. FAULDING & CO. LIMITED (AU) | 1994-02-17 | — | — | WO | claimed |
| EP-0122815-B1 | ENTERIC-SOLUBLE PREPARATIONS AND A PROCESS FOR THEIR PRODUCTION | SANKYO COMPANY LIMITED (JP) | 1989-10-25 | — | — | EP | claimed |
| EP-0108504-B1 | A PROCESS FOR COATING SOLID PHARMACEUTICAL PREPARATIONS AND COATED PREPARATIONS THUS OBTAINED | SANKYO COMPANY LIMITED (JP) | 1987-05-13 | — | — | EP | claimed |
| US-4661162-A | MIXTURE OF POLYMER WITH POLYANIONIC POLYMER WHICH IS SOLUBLE AT LOW PH | SANKYO COMPANY, LIMITED (JP) | 1987-04-28 | — | — | US | claimed |
| US-4497847-A | MONO AND DIESTERS OF GLYCEROL AND SATURATED CARBOXYLIC ACIDS AS PLASTICIZERS | SANKYO COMPANY, LIMITED (JP) | 1985-02-05 | — | — | US | claimed |
| EP-0122815-A1 | Enteric-soluble preparations and a process for their production | SANKYO COMPANY LIMITED (JP) | 1984-10-24 | — | — | EP | claimed |
| EP-0108504-A1 | A process for coating solid pharmaceutical preparations and coated preparations thus obtained | SANKYO COMPANY LIMITED (JP) | 1984-05-16 | — | — | EP | claimed |
| US-4335099-A | Employment of enteric coated IgA for hypoproteinemia in intestinal infectious diseases | THE GREEN CROSS CORPORATION (JP) | 1982-06-15 | — | — | US | claimed |
| US-4134809-A | GLYCIDYL ACRYLATES, ADHESIVE METAL COATINGS | EASTMAN KODAK COMPANY (US) | 1979-01-16 | — | — | US | claimed |